Gene therapies for BCG-unresponsive bladder cancer have high response rates.

Published Date: 10 May 2024

Complete responses were seen in 75% of patients, and these were generally found to be long-lasting.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

2.

In early dementia, SSRIs enhance cognition and major depression.

3.

FDA Approves CAR-T Product Use for Myeloma Early.

4.

For Localized Prostate Cancer, HIFU Is Not Worse Than Prostatectomy.

5.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot